Also on Trial Friend:Focal Segmental Glomerulosclerosis pageMatch Me
All 25 Focal Segmental Glomerulosclerosis trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)Most sites in California, Texas and FloridaRecruitingPhase 3Ages 12+Boehringer Ingelheim74US sites
25 states - Nephrotic Syndrome Study NetworkMost sites in New York, California and PennsylvaniaRecruitingUp to age 80University of Michigan34US sites
16 states - A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)Most sites in Florida, California and TexasRecruitingPhase 2Ages 18+Akebia Therapeutics31US sites
16 states - A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARBMost sites in California, Colorado and FloridaRecruitingPhase 3Ages 12-80Dimerix Bioscience Pty20US sites
12 states - A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseMost sites in Texas, California and IllinoisRecruitingPhase 2Ages 16-75Sanofi17US sites
12 states - Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesMost sites in Florida, New Jersey and North CarolinaRecruitingPhase 2Ages 1-17Travere Therapeutics17US sites
14 states - NEPTUNE Match StudyMost sites in Washington, New York and PennsylvaniaRecruitingAges 1-80University of Michigan15US sites
11 states - Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 SystemMost sites in California, South Carolina and DelawareRecruitingUp to age 75Kaneka Medical America10US sites
8 states - Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in ChildrenMost sites in California, Delaware and MichiganRecruitingUp to age 21Kaneka Medical America10US sites
9 states - Study of WAL0921 in Patients With Glomerular Kidney DiseasesMost sites in Texas, California and ColoradoRecruitingPhase 2Ages 18-75Walden Biosciences9US sites
7 states - A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)Most sites in New York and PennsylvaniaRecruitingAges 3-17Northwell Health2US sites
2 states - A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental GlomerulosclerosisMost sites in Illinois and New YorkRecruitingPhase 2/3Ages 18+Apellis Pharmaceuticals2US sites
2 states - AMPK-activation by Metformin in FSGS: AMP-FSGSMost sites in Connecticut and New YorkRecruitingPhase 1/2Ages 18-80Yale University2US sites
2 states - taVNS for FRNS in ChildrenMost sites in New York and PennsylvaniaRecruitingAges 3-17Northwell Health2US sites
2 states - An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte DiseasesOnly in MarylandRecruitingPhase 2Ages 18-115National Human Genome Research Institute (NHGRI)1US site
- Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.Only in MichiganRecruitingAges 2+University of Michigan1US site
- Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change DiseaseOnly in MichiganRecruitingUniversity of Michigan1US site
- SLIT ABS: Study on Patients With Autoimmune PodocytopathyOnly in MinnesotaRecruitingAges 0-99Meyer Children's Hospital IRCCS1US site
- A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental GlomerulosclerosisRecruitingPhase 2/3Ages 18-75Bio-Thera SolutionsNo US site yet
- ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and BiobankRecruitingUp to age 75Christoph AufrichtNo US site yet
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Focal Segmental Glomerulosclerosis trials in the US, and what stage they are in
Of the 18 Focal Segmental Glomerulosclerosis trials with a US site, 3 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 6 of them. The remaining 9 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 9 of them, and universities, hospitals, foundations and government groups run 9. The sponsors with the most are University of Michigan (4), Kaneka Medical America (2) and Northwell Health (2). The most recently listed one first appeared on ClinicalTrials.gov on April 8, 2026.
Focal Segmental Glomerulosclerosis trials in the US, state by state
Of the 18 Focal Segmental Glomerulosclerosis trials with a US site, 13 accept children under 18. Their open sites are in 32 states, most often Michigan, New York and North Carolina. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 26 states
US hospitals running the most Focal Segmental Glomerulosclerosis trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Focal Segmental Glomerulosclerosis.
- Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania4 trials
- University of MichiganAnn Arbor, Michigan4 trials
- Cohen Children's Medical CenterNew Hyde Park, New York3 trials
- Seattle Children's HospitalSeattle, Washington3 trials
- University of North CarolinaChapel Hill, North Carolina3 trials
- Akron Children's HospitalAkron, Ohio2 trials
- Cedars-Sinai Medical CenterLos Angeles, California2 trials
- Children's Mercy HospitalKansas City, Missouri2 trials
- Columbia University Medical CenterNew York, New York2 trials
- Hackensack University Medical CenterHackensack, New Jersey2 trials
Help getting to a Focal Segmental Glomerulosclerosis trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Focal Segmental Glomerulosclerosis trial near you
Are there Focal Segmental Glomerulosclerosis clinical trials near me?
As of November 13, 2026, 25 Focal Segmental Glomerulosclerosis clinical trials are recruiting now and 3 are not yet recruiting. In the US, 18 of them have at least 1 open site, across 36 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Focal Segmental Glomerulosclerosis clinical trial sites?
Recruiting Focal Segmental Glomerulosclerosis trials list open sites in 36 states. New York, Michigan and California have the most, and the table on this page lists every state.
Are there Focal Segmental Glomerulosclerosis trials for children near me?
Of the 18 Focal Segmental Glomerulosclerosis trials with a US site, 13 accept children under 18. Their open sites are in 32 states, most often Michigan, New York and North Carolina. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Focal Segmental Glomerulosclerosis clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.
What if there is no Focal Segmental Glomerulosclerosis trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Focal Segmental Glomerulosclerosis trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Focal Segmental Glomerulosclerosis: Filspari (sparsentan).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.